CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Ryvu Therapeutics SA Company Snapshot
Ryvu Therapeutics SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ryvu Therapeutics SA with three other miscellaneous service companies in Europe: Cellectis SA of France (2018 sales of 18.19 million Euro [US$20.08 million] of which 98% was Therapeutics), Oncodesign Sa of France (20.09 million Euro [US$22.17 million] ), and Puretech Health Plc which is based in the United Kingdom (£15.59 million [US$20.04 million] of which 89% was Affiliates).

Sales Analysis. During the year ended December of 2018, sales at Ryvu Therapeutics SA were 77.21 million Polish New Zlotys (US$19.93 million). This is an increase of 14.3% versus 2017, when the company's sales were 67.54 million Polish New Zlotys. This was the fifth consecutive year of sales increases at Ryvu Therapeutics SA (and since 2013, sales have increased a total of 491%). Sales of Services saw an increase that was more than double the company's growth rate: sales were up 33.6% in 2018, from 44.21 million Polish New Zlotys to 59.08 million Polish New Zlotys. Ryvu Therapeutics SA also saw significant increases in sales in Bioinformatic (up 24.3% to 8.56 million Polish New Zlotys) . Not all segments of Ryvu Therapeutics SA experienced an increase in sales in 2018: sales of Innovative fell 73.5% to 9.74 million Polish New Zlotys.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Ryvu Therapeutics SA
  Stock Performance Chart for Ryvu Therapeutics SA
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 44.80
(Figures in Polish New Zlotys)
1 Week -7.4%   13 Weeks -8.4%  
4 Weeks -25.3%   52 Weeks -15.5%  
 
Ryvu Therapeutics SA Key Data:
  Ticker: RVU Country: Poland
  Exchanges: WAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 77,205,571
(Year Ending Jan 2019).
Employees: 553
  Currency: Polish New Zlotys Market Cap: 715,511,059
  Fiscal Yr Ends: December Shares Outstanding: 15,971,229
  Share Type: Ordinary Closely Held Shares: 5,915,264
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.